首页> 外文期刊>General Pharmacology >Dual mechanisms of action of interferon-gamma in potentiating responses to LPS in mice: IL1, TNFalpha and IL6 production in serum and hypothermia.
【24h】

Dual mechanisms of action of interferon-gamma in potentiating responses to LPS in mice: IL1, TNFalpha and IL6 production in serum and hypothermia.

机译:干扰素-γ增强小鼠LPS应答的双重作用机制:血清和体温过低产生IL1,TNFα和IL6。

获取原文
获取原文并翻译 | 示例
           

摘要

IFNgamma potentiates the production of serum cytokines and mortality induced by LPS, but these responses do not change in parallel, and the underlying mechanisms are not clear. Pretreatment of mice with 15 microg rrIFNgamma intraperitoneally (IP) resulted in potentiation of LPS-induced serum cytokine production and hypothermia, but these changes depended on the pretreatment time and did not occur in parallel. TNFalpha and IL1beta levels showed peak potentiation after 8-h-IFNgamma pretreatment which may result from a process of sensitization of mechanisms involved in LPS responses. IL6 levels were most markedly potentiated after 3- and 6-h-IFNgamma-pretreatment and hypothermia was markedly potentiated after 0-8 h pretreatments. These effects may result from an additional synergistic action of IFNgamma with other mediators when it is present at significant levels earlier after its injection, given that IFNgamma had little (hypothermia) or no effect (cytokines) alone. The degree of potentiation induced by 18-h-IFNgamma pretreatment was related to the dose of LPS, the maximum response having been increased. Two injections of IFNgamma at 42 and 18 h prior to LPS induced greater increases in TNFalpha and IL1beta production than 18-h pretreatment alone, but not in IL6 production or hypothermia. There may be a maximum level of IL6 production which was surpassed under these conditions. These findings suggest that a balance of sensitizing and synergistic actions of IFNgamma with other mediators such as IL1 and TNFalpha, are the major mechanisms underlying its potentiation of LPS responses in mice.
机译:IFNγ增强了LPS诱导的血清细胞因子的产生和死亡率,但这些反应并没有同时改变,其潜在机制尚不清楚。腹膜内(IP)15微克rrIFNgamma预处理小鼠可增强LPS诱导的血清细胞因子生成和体温过低,但这些变化取决于预处理时间,因此不会并行发生。 TNFalpha和IL1beta水平显示了8-h-IFNgamma预处理后的峰值增强作用,这可能是由LPS应答机制的致敏过程引起的。在进行3和6小时的IFNγ预处理后,IL6水平最显着增强,而在0至8小时的预处理后,低温显着增强。这些作用可能是由于IFNgamma注射后较早以显着水平存在时,它与其他介质的额外协同作用所致,因为IFNgamma仅具有很少的作用(低体温)或没有作用(细胞因子)。 18-h-IFNγ预处理诱导的增强程度与LPS的剂量有关,最大反应有所增加。 LPS之前42和18小时两次注射IFNgamma诱导的TNFalpha和IL1beta产生的增加比单独的18小时预处理更大,但IL6产生或体温过低则没有。在这些条件下可能会超过IL6的最高产量。这些发现表明,IFNgamma与其他介质(例如IL1和TNFalpha)的敏化和协同作用之间的平衡是其增强小鼠LPS反应的主要机制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号